BRCA2 and neoplasm: HMGN4 upregulation in mouse and human cells and the thyroid gland of transgenic mice alters cellular transcriptional profiles, downregulates the expression of the tumor suppressors, including Atm, Atrx, and Brca2, and elevates the level of the DNA damage-marker, γH2AX.